Transcripts Formycon AG

Equities

FYB

DE000A1EWVY8

Biotechnology & Medical Research

Real-time Estimate Tradegate Other stock markets 16:02:16 14/01/2026 GMT			5-day change	1st Jan Change
25.20 ^EUR	-2.51%		-1.75%	-1.17%

12-23	Formycon Obtains US FDA Approval for Interchangeable Lucentis Biosimilar	MT
12-23	Formycon AG - FDA approves biologics license application (BLA) for additional ranibizumab biosimilar under trade name Nufymco	RE

Transcripts

11-13	Formycon AG, Q3 2025 Earnings Call, Nov 13, 2025
13/08/25	Formycon AG, Q2 2025 Earnings Call, Aug 13, 2025
12/05/25	Formycon AG, Q1 2025 Earnings Call, May 12, 2025
27/03/25	Formycon AG, 2024 Earnings Call, Mar 27, 2025
17/02/25	Formycon AG - Special Call
28/11/24	Formycon AG, Nine Months 2024 Earnings Call, Nov 28, 2024
09/11/21	Formycon Ag Provides Group Revenue Guidance for the Year 2021	CI
21/09/21	Formycon AG Provides Revenue Guidance for the Year 2021	CI
30/06/21	Formycon AG Provides Sales Guidance for the Fiscal Year 2021	CI
11/11/20	Formycon AG Provides Revenue Guidance for the Fiscal Year of 2020	CI
22/06/20	Formycon AG Provides Earning Guidance for the Full Year 2020	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!